Page last updated: 2024-10-25

cyclandelate and Intracranial Arteriosclerosis

cyclandelate has been researched along with Intracranial Arteriosclerosis in 1 studies

Cyclandelate: A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
cyclandelate : The ester obtained by formal condensation of mandelic acid and 3,3,5-tricyclohexanol. It is a direct-acting smooth muscle relaxant used to dilate blood vessels.

Intracranial Arteriosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.

Research Excerpts

ExcerptRelevanceReference
"Twenty-one patients with cerebral arteriosclerosis were treated for twelve months with placebo or cyclandelate (Cyclospasmol), 400 mg four times daily, in a double-blind study with medication cross-over after six months."9.04Cyclandelate in the treatment of cerebral arteriosclerosis. ( Hall, P, 1976)
"Twenty-one patients with cerebral arteriosclerosis were treated for twelve months with placebo or cyclandelate (Cyclospasmol), 400 mg four times daily, in a double-blind study with medication cross-over after six months."5.04Cyclandelate in the treatment of cerebral arteriosclerosis. ( Hall, P, 1976)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hall, P1

Trials

1 trial available for cyclandelate and Intracranial Arteriosclerosis

ArticleYear
Cyclandelate in the treatment of cerebral arteriosclerosis.
    Journal of the American Geriatrics Society, 1976, Volume: 24, Issue:1

    Topics: Aged; Cyclandelate; Drug Evaluation; Female; Humans; Intracranial Arteriosclerosis; Long-Term Care;

1976